Skip to main content
SpringerLink
Log in
Book cover

Blasenkarzinom pp 109–123Cite as

Therapie und Prognose des lymphogen metastasierten Urothelkarzinoms — Stellenwert der Lymphknotenchirurgie und der perioperativen systemischen Chemotherapie.

  • Conference paper

This is a preview of subscription content, log in via an institution.

eBook
USD   9.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Advanced Bladder Cancer Meta-analysis Collaboration (2003) Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis. Lancet 361: 1927–1934

    Google Scholar 

  • Bredael JJ, Croker BP, Glenn JF (1980) The curability if invasive bladder cancer treated by radical cystectomy. Eur Urol 6: 206–210

    PubMed  CAS  Google Scholar 

  • Dretler SP, Ragsdale BD, Leadbetter WF (1973) The value of pelvic lymphadenectomy in the surgical treatment of bladder cancer. J Urol 109: 414–416

    PubMed  CAS  Google Scholar 

  • Feinstein AR, Sosin DM, Wells CK (1985) The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312: 1604–1608

    PubMed  CAS  Google Scholar 

  • Freiha F, Reese J, Torti FM (1996) A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. J Urol 155: 495–499

    PubMed  CAS  Google Scholar 

  • Grossman HB, Natale RB, Tangen CM, Speights VO, Vogelzang NJ, Trump DL, deVere White RW, Sarosdy MF, Wood DP, Jr., Raghavan D, Crawford ED (2003) Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349: 859–866

    Article  PubMed  CAS  Google Scholar 

  • Gschwend JE, Fair WR, Vieweg J (2000) Radical cystectomy for invasive bladder cancer: contemporary results and remaining controversies. Eur Urol 38: 121–130

    Article  PubMed  CAS  Google Scholar 

  • Gschwend JE, Volkmer BG, Hautmann RE (2004) Radical cystectomy for bladder cancer in the neobladder era — progression and survival in 674 consecutive patients. J Urol 171(suppl): 80

    Google Scholar 

  • Hack M, Gerber M, Dilk O, Albers P, Fechner G, Wülfing C, Piechota H, Loch T, Lehmann T, Stöckle M (2004) Long-term survival of patients with metastatic transitional cell carcinoma treated with a combined-modality approach of chemotherapy and metastasectomy. J Urol 171(suppl):82

    Google Scholar 

  • Herr HW (2003) Superiority of ratio based lymph node staging for bladder cancer. J Urol 169: 943–945

    PubMed  Google Scholar 

  • Herr HW, Donat SM, Bajorin DF (2001) Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancer. J Urol 165: 811–814

    Article  PubMed  CAS  Google Scholar 

  • Leadbetter WF, Cooper JF (1950) Regional gland dissection for carcinoma of the bladder: a technique for one-stage cystectomy, gland dissection and bilateral uretero-enterostomy. J Urol 63: 242–247

    PubMed  CAS  Google Scholar 

  • Lehmann J, Retz M, Weining C, Albers P, Frohneberg D, Becker T, Funke P, Sternberg D, Wellek S, Stöckle M, members of the AUO AB 05/95 trial group (2003) Adjuvant cisplatin, methotrexate (CM) versus methotrexate, vinblastine, epirubicin, and cisplatin (MVEC) for locally advanced bladder cancer: A large, randomized, multicenter trial. Proc Am Soc Clin Oncol 22: 391

    Google Scholar 

  • Leissner J, Hohenfellner R, Thuroff JW, Wolf HK (2000) Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int 85: 817–823

    Article  PubMed  CAS  Google Scholar 

  • Poulsen AL, Horn T, Steven K (1998) Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol 160: 2015–2019

    PubMed  CAS  Google Scholar 

  • Reid EC, Oliver JA, Fishman IJ (1976) Preoperative irradiation and cystectomy in 135 cases of bladder cancer. Urology 8: 247–250

    Article  PubMed  CAS  Google Scholar 

  • Skinner DG (1982) Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference. J Urol 128: 34–36

    PubMed  CAS  Google Scholar 

  • Skinner DG, Daniels JR, Russell CA, Lieskovsky G, Boyd SD, Nichols P, Kern W, Sakamoto J, Krailo M, Groshen S (1991) The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol 145: 459–464

    PubMed  CAS  Google Scholar 

  • Smith JA, Whitmore WF (1981) Regional lymph node metastasis from bladder cancer. J Urol 126: 591–593

    PubMed  Google Scholar 

  • Stadler WM, Lerner SP (2003) Perioperative chemotherapy in locally advanced bladder cancer. Lancet 361: 1922–1923

    Article  PubMed  Google Scholar 

  • Stein JP, Cai J, Groshen S, Skinner DG (2003) Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol 170: 35–41

    Article  PubMed  Google Scholar 

  • Sternberg CN, Yagoda A, Scher HI, Watson RC, Ahmed T, Weiselberg LR, Geller N, Hollander PS, Herr HW, Sogani PC (1985) Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. J Urol 133: 403–407

    PubMed  CAS  Google Scholar 

  • Stöckle M, Meyenburg W, Wellek S, Voges G, Gertenbach U, Thuroff JW, Huber C, Hohenfellner R (1992) Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study. J Urol 148: 302–306

    PubMed  Google Scholar 

  • Sweeney P, Millikan R, Donat M, Wood CG, Radtke AS, Pettaway CA, Grossman HB, Dinney CP, Swanson DA, Pisters LL (2003) Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder? J Urol 169: 2113–2117

    PubMed  Google Scholar 

  • Sylvester R, Collette L (2001) When do statistics lie? UroOncol 1: 185–194

    Google Scholar 

  • Whitmore WF, Marshal V (1962) Radical total cystectomy for cancer of the bladder: 230 consecutive cases five years later. J Urol 87: 853–862

    PubMed  Google Scholar 

  • Wishnow KI, Tenney DM (1991) Will Rogers and the results of radical cystectomy for invasive bladder cancer. Urol Clin North Am 18: 529–537

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Urologie und Kinderurologie, Universitätskliniken des Saarlandes, Kirrberger Straße, 66421, Homburg/Saar

    M. Stöckle & J. Lehmann

Authors
  1. M. Stöckle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Lehmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Medizin Verlag Heidelberg

About this paper

Cite this paper

Stöckle, M., Lehmann, J. (2005). Therapie und Prognose des lymphogen metastasierten Urothelkarzinoms — Stellenwert der Lymphknotenchirurgie und der perioperativen systemischen Chemotherapie.. In: Blasenkarzinom. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26850-2_10

Download citation

  • DOI: https://doi.org/10.1007/3-540-26850-2_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-20504-3

  • Online ISBN: 978-3-540-26850-5

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation